RoMEA Radiopharmaceuticals Market to 2032
Overview
The RoMEA Radiopharmaceuticals Market is expected to reach a 54.60 USD Billion by 2032 and is projected to grow at a CAGR of 3.93% from 2025 to 2032.
Revenue, 2024 (USD Billion)
43.92
Forecast, 2032 (USD Billion)
54.60
CAGR, 2024 - 2032
3.93%
Report Coverage
RoMEA
RoMEA Radiopharmaceuticals Market 2018-2032 USD Billion
RoMEA Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 43.92 USD Billion
- Projected Market Size (2032): 54.60 USD Billion
- CAGR (2025-2032): 3.93%
Key Findings of RoMEA Radiopharmaceuticals Market
- The RoMEA Radiopharmaceuticals Market was valued at 54.60 USD Billion in 2024.
- The RoMEA Radiopharmaceuticals Market is likely to grow at a CAGR of 3.93% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Therapeutic in By Application Segment accounted for the largest share of the market with a revenue of 43.92 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 4.55% during the forecast period from 2024 to 2032.
RoMEA Radiopharmaceuticals Market Scope
RoMEA Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Diagnostic
- Therapeutic
By Source
- Cyclotrons
- Nuclear Reactors
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
RoMEA Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 43.92 USD Billion |
| Market Value in 2032 | 54.60 USD Billion |
| CAGR (2025-2032) | 3.93% |
| Historic Data | 2016-2023 |
| Market Segments Covered | By Type,By Application,By Source,End User |
Regional Insights:
-
Leading Market (2024-2032): RoMEA, leading in terms of revenue 43.92 USD Billion in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 43.92 USD Billion in 2024.
Segments and Scope
-
RoMEA Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in RoMEA Radiopharmaceuticals Market to 2032 with a revenue of 25.49 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in RoMEA Radiopharmaceuticals Market to 2032 with a Growth rate of 4.37 % in forecast period 2025-2032.
-
RoMEA Radiopharmaceuticals Market to 2032, By By Application
- Therapeutic is the largest segment in RoMEA Radiopharmaceuticals Market to 2032 with a revenue of 43.92 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in RoMEA Radiopharmaceuticals Market to 2032 with a Growth rate of 3.93 % in forecast period 2025-2032.
-
RoMEA Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in RoMEA Radiopharmaceuticals Market to 2032 with a revenue of 26.85 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in RoMEA Radiopharmaceuticals Market to 2032 with a Growth rate of 4.30 % in forecast period 2025-2032.
-
RoMEA Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in RoMEA Radiopharmaceuticals Market to 2032 with a revenue of 17.80 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in RoMEA Radiopharmaceuticals Market to 2032 with a Growth rate of 4.55 % in forecast period 2025-2032.
RoMEA Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE HealthCare | |||
| Lantheus | |||
| Curium and its affiliates | |||
RoMEA Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
RoMEA Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoMEA Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
RoMEA Radiopharmaceuticals Market was valued at USD 43.92(Revenue in USD Billion) in 2021.
RoMEA Radiopharmaceuticals Market is projected to grow at a CAGR of 3.93% during the forecast period of 2024 to 2032.
The Therapeutic segment is expected to dominate the RoMEA Radiopharmaceuticals Market, holding a largest market share of 43.92 USD Billion in 2024
RoMEA Radiopharmaceuticals Market Scope
RoMEA Radiopharmaceuticals Market Segmentation & Scope
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Diagnostic
- Therapeutic
By Source
- Cyclotrons
- Nuclear Reactors
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
Frequently Asked Questions
The RoMEA Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
RoMEA Radiopharmaceuticals Market was valued at USD 43.92(Revenue in USD Billion) in 2021.
RoMEA Radiopharmaceuticals Market is projected to grow at a CAGR of 3.93% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Radiopharmaceuticals Market for final year is USD 54.60 (USD Billion).
RoMEA Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The RoMEA Radiopharmaceuticals Market is segmented based on Segmentation By Type,By Application,By Source,End User.
RoMEA Radiopharmaceuticals Market was valued at USD 43.92(Revenue in USD Billion) in 2021.
RoMEA Radiopharmaceuticals Market is projected to grow at a CAGR of 3.93% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Radiopharmaceuticals Market for final year is USD 54.60 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.